Vadim Koshkin

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Vadim Koshkin
Jun 8, 2025, 22:13 | Insight
Koral Shah: Human Epidermal Growth Factor Receptor 2 Testing in Urothelial Carcinoma
Koral Shah, Fellow at City of Hope, shared a post on X: "HER2 in UC…
Jan 14, 2025, 07:59 | Science
Vadim Koshkin: Genomic Biomarkers Associated with EV Outcomes for Patients with Advanced Urothelial Carcinoma
Vadim Koshkin, Associate Professor of Clinical Medicine UC San Francisco, shared a recent article by…
Oct 28, 2024, 13:09 | Insight
Petros Grivas: Stellar Faculty covering Genitourinary Cancers
Petros Grivas, Clinical Director of the Genitourinary Cancers Program at the University of Washington and…
Sep 26, 2024, 16:11 | Blog
Chandler Park: Learning the latest cutting edge data to help our cancer patients at ESMO 24
Chandler Park shared a post on Linkedin: ''ESMO was FUN! Loved learning the latest cutting…
Sep 24, 2024, 05:30 | Insight
Ana I. Velázquez Mañana: Best Poster in Urothelial Cancers at ESMO24 by Amanda Nizam
Ana I. Velázquez Mañana shared a post on X: "Congratulations Amanda Nizam, mentor Vadim Koshkin…
Sep 23, 2024, 14:21 | Blog
Albert Jang: First ESMO24 experience in Barcelona
Albert Jang, Internal Medicine Resident at Tulane University School of Medicine, shared on X: ''Had…
Sep 16, 2024, 11:12 | Blog
Pedro C Barata: Data on novel IO-combo futibatinib+pembro
Pedro C Barata, Associate Professor at University Hospitals Seidman Cancer Center, shared on LinkedIn: "So…
Sep 15, 2024, 12:53 | Blog
Sumanta Pal's highlights from ESMO24
The ESMO Congress 2024 is ongoing in Barcelona, from September 13 to 17, 2024, at the…
Jul 13, 2024, 17:18 | Career
Vadim Koshkin was promoted to Associate Professor at UCSF
Vadim Koshkin, Associate Professor of Clinical Medicine UC San Francisco, posted on X: "Finally posting…
Jun 1, 2024, 23:26 | Blog
Vadim Koshkin: Our recent work highlighting a Grey Zone in metastatic urothelial carcinoma after enfortumab vedotin/pembrolizumab
Vadim Koshkin, Assistant Professor at University of California, San Francisco, shared a post on X/Twitter:…
Apr 28, 2024, 10:46 | Insight
Sumanta Pal: Kicking off our Southern California Regional Collaborative journal club
Sumanta Pal, Head of the Kidney and Bladder Cancer Disease at City of Hope Medical…
Feb 16, 2024, 17:48 | Blog
Mohammad Jad Moussa: "La Crème de La Crème" panel discussing wealthy outcomes from the UNITE study
Mohammad Jad Moussa, Postdoc Fellow of GU Oncology at MD Anderson Cancer Center, recently shared…
Jan 5, 2024, 11:46 | Blog
Petros Grivas: This is a product of teamwork for many years
Petros Grivas, Associate Professor at University of Washington, shared on X/Twitter: "This is a product of…
Nov 7, 2023, 03:03 | Dialogues
5min OncoDaily Updates with Chandler Park: Vadim Koshkin discusses an innovative positive study of re-challenging patients with immunotherapy for metastatic bladder cancer patient
Oct 24, 2023, 19:58 | Blog
Elizabeth Plimack: Kudos to Amanda Nizam for winning Best ESMO2023 Poster in Urothelial
Elizabeth Plimack, Deputy Director Fox Chase Cancer Center, made the following post on Twitter: "Kudos…
All: 15 Posts: 1 - 100
Special Coverage